Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety and tolerability of oral
omadacycline as compared to placebo in the treatment of adults with Nontuberculous
Mycobacterial (NTM) pulmonary disease caused by Mycobacterium abscessus complex (MABc)